Metatron (MRNJ) Launches Cannaboids.com A Medical Marijuana Community Portal

DOVER, DE / ACCESSWIRE / May 24, 2016 / Metatron is pleased to announce it has launched Cannaboids.com an Organic Nutraceuticals Portal, where medical marijuana patients can find the latest CBD news and connect to legal dispensaries. We also plan to release a Cannaboid branded app in the near future. CBD is an abbreviation for cannabidiol, a prominent naturally-occurring cannabinoid compound that has significant medical benefits. CBD can be made from the mature stalks of the industrial hemp plants and can be legally imported into the United States under Federal Law.

Scientific and clinical studies underscore CBD’s potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuroprotective and neurogenic effects, and its anti- cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.

Metatron was the first company to ever have a hemp related app on iTunes and now has over 700 apps on sale, with 3 million plus in downloads and sales. Our focus lies in the health, fitness, and entertainment categories. High profile clients include Eckhart Tolle, Sounds True, Gary Zukav, Denise Druce, Mind Motivations, Effective Learning Systems, Travelvideostore.com and many others.

Website: http://metatroninc.com/
Facebook: http://www.facebook.com/metatroninc
Facebook: http://www.facebook.com/iMobilize
News: https://metatroninc.wordpress.com
Twitter: http://twitter.com/metatroninc
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc

Investor Relations: PACIFIC EQUITY ALLIANCE LLC Investor Contact(s): Zachary R. Logan / Grady Powell Contact phone: 858.886.7238 info@pacificequityusa.com or ir@metatroninc.com.

Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services. Metatron does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

SOURCE: Metatron Inc.

ReleaseID: 440353